1. Home
  2. PSTV vs DUO Comparison

PSTV vs DUO Comparison

Compare PSTV & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • DUO
  • Stock Information
  • Founded
  • PSTV 1996
  • DUO 2011
  • Country
  • PSTV United States
  • DUO China
  • Employees
  • PSTV N/A
  • DUO N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • DUO Real Estate
  • Sector
  • PSTV Health Care
  • DUO Finance
  • Exchange
  • PSTV Nasdaq
  • DUO Nasdaq
  • Market Cap
  • PSTV 10.4M
  • DUO 11.4M
  • IPO Year
  • PSTV N/A
  • DUO 2019
  • Fundamental
  • Price
  • PSTV $0.33
  • DUO $2.12
  • Analyst Decision
  • PSTV Strong Buy
  • DUO
  • Analyst Count
  • PSTV 3
  • DUO 0
  • Target Price
  • PSTV $10.83
  • DUO N/A
  • AVG Volume (30 Days)
  • PSTV 59.8M
  • DUO 175.2K
  • Earning Date
  • PSTV 08-13-2025
  • DUO 08-29-2025
  • Dividend Yield
  • PSTV N/A
  • DUO N/A
  • EPS Growth
  • PSTV N/A
  • DUO N/A
  • EPS
  • PSTV N/A
  • DUO 7.57
  • Revenue
  • PSTV $5,206,000.00
  • DUO $46,458,330.00
  • Revenue This Year
  • PSTV $13.26
  • DUO N/A
  • Revenue Next Year
  • PSTV $8.84
  • DUO N/A
  • P/E Ratio
  • PSTV N/A
  • DUO $0.28
  • Revenue Growth
  • PSTV N/A
  • DUO 19.00
  • 52 Week Low
  • PSTV $0.16
  • DUO $1.97
  • 52 Week High
  • PSTV $2.31
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 48.42
  • DUO 30.05
  • Support Level
  • PSTV $0.30
  • DUO $1.97
  • Resistance Level
  • PSTV $0.37
  • DUO $2.49
  • Average True Range (ATR)
  • PSTV 0.05
  • DUO 0.16
  • MACD
  • PSTV 0.02
  • DUO -0.00
  • Stochastic Oscillator
  • PSTV 59.39
  • DUO 19.44

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: